Financial Ratios

SOLVAY PHARMA INDIA LTD. (AMALGAMATED)

NSE : NABSE : 532447ISIN CODE : INE593D01010Industry : Pharmaceuticals & DrugsHouse : Solvay Pharma - MNC
BSE2141.550 (0 %)
PREV CLOSE ( ) 2141.55
OPEN PRICE ( ) 2150.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 81
TODAY'S LOW / HIGH ( )2140.00 2150.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsDec2010Dec2009Dec2008Dec2007Dec2006
Operational & Financial Ratios
   Earnings Per Share (Rs)100.7079.2764.9655.6837.09
   CEPS(Rs)107.0488.3267.5965.5246.18
   DPS(Rs)25.5032.5017.5040.008.00
   Book NAV/Share(Rs)328.59257.62216.38171.89162.51
   Tax Rate(%)32.9534.0134.6734.4636.56
Margin Ratios
   Core EBITDA Margin(%)24.2324.2621.8224.1119.40
   EBIT Margin(%)25.1124.4523.5923.4418.80
   Pre Tax Margin(%)25.1124.4523.5923.4218.75
   PAT Margin (%)16.8416.1315.4115.3511.89
   Cash Profit Margin (%)17.9017.9716.0318.0614.81
Performance Ratios
   ROA(%)26.2524.7024.2425.1619.09
   ROE(%)34.3633.4533.4633.3024.97
   ROCE(%)51.2550.6951.2350.8439.42
   Asset Turnover(x)1.561.531.571.641.61
   Sales/Fixed Asset(x)4.775.397.476.526.03
   Working Capital/Sales(x)2.372.733.092.702.64
Efficiency Ratios
   Fixed Capital/Sales(x)0.210.190.130.150.17
   Receivable days18.5124.9029.9330.9031.28
   Inventory Days52.8566.7768.2246.2247.50
   Payable days76.3891.22104.5684.6782.45
Valuation Parameters
   PER(x)19.8122.108.6112.6513.43
   PCE(x)18.6419.848.2810.7510.78
   Price/Book(x)6.076.802.594.103.06
   Yield(%)1.281.853.135.681.61
   EV/Net Sales(x)3.243.441.381.971.46
   EV/Core EBITDA(x)12.1013.005.356.926.16
   EV/EBIT(x)12.6113.715.497.727.11
   EV/CE(x)4.394.901.792.851.96
   M Cap / Sales3.423.661.412.121.75
Growth Ratio
   Net Sales Growth(%)21.9320.6619.4116.4311.07
   Core EBITDA Growth(%)23.5624.117.6240.073.50
   EBIT Growth(%)25.0420.7916.9845.024.06
   PAT Growth(%)27.0322.0216.6750.142.80
   EPS Growth(%)27.0322.0216.6750.142.80
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)3.353.192.443.123.27
   Quick Ratio(x)2.362.371.252.412.37
   Interest Cover(x)0.000.004116.601460.26360.60
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.